Denver, CO (PRWEB) January 15, 2009
LegalView.info, the number one resource for everything and anything legal available on the Web, recently updated its traumatic brain injury information blog readers with news of the development of a long-term study that will likely increase treatments of TBI patients as well as improve upon rehabilitation therapies, according to a January article from the Chicago Tribune. The study is being lead by several health care research facilities from both the United States and Canada, and it is being funded with a $4.3 million grant by the National Institutes of Health (NIH). The study will take approximately five years to complete, but could affect the implementation of traumatic brain injury treatments for years to come.
Patients who have suffered from a traumatic brain injury incident are encouraged to speak with a health care professional as well as a neurologist who can better administer an appropriate and accurate diagnosis, which will increase the implementation of treatment therapies. However, because of the legalities surrounding a potential TBI incident, it is also advisable for a brain-injured victim to speak with a TBI law firm that can provide several brain injury lawyers and attorneys to choose from. Speaking with a legal professional on the development of a brain injury lawsuit will improve the likelihood that monetary compensation is received on behalf of a TBI victim.
LegalView also offers a wealth of legal information available through its practice areas, which house topics such as the Byetta and Avandia risks as well as the latest on mesothelioma treatments.
Both Byetta and Avandia are used to treat type 2 diabetes patients. However, both drugs have been continually making news headlines for dangerous side effects associated with their consumption.
Byetta, also known as exenatide, is a treatment of type 2 diabetes that uses an injectable form of insulin to regulate glucose levels of non-insulin dependent patients. In the last several months, Byetta has been linked to the onset of pancreatitis among Byetta patients. Pancreatitis is a condition in which the pancreas becomes inflamed and actually begins to attack itself, according to the Mayo Clinic. Those who have consumed Byetta and feel they may be at risk for the Byetta side effects should contact a medical professional immediately.
Similar to Byetta is that of Avandia, which also treats type 2 diabetes, but does so internally by regulating the natural insulin production of a patient. It too has been linked to dangerous side effects ranging from heart failure and heart disease to bone fractures among women and the early onset of osteoporosis among patients. Individuals consuming Avandia can learn more about the dangers surrounding the drug by contacting a pharmaceutical attorney and developing a potential Avandia class action lawsuit, which may be necessary to obtain compensation for damages incurred -- both physically and mentally.
In addition to the most up-to-date news on pharmaceutical controversies, LegalView also offers information on rare disorders and condition such as mesothelioma. This condition is caused by the inhalation of asbestos fibers and dust that begin to form cancerous cells on the lining of the lungs and internal organs. It is often a deadly and painful condition, which has few treatment options and a low life expectancy upon diagnosis. Individuals who suffer from mesothelioma can receive a free legal consultation as to the dangers and potential clinical trials/treatments by contacting a mesothelioma lawyer.
Legalview.info is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of Legalview.info's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.Legalview.info/.